Enokizumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized (from mouse) |
| Target | IL9 |
| Clinical data | |
| ATC code | none |
| Identifiers | |
| ChemSpider | none |
| UNII |
I4BE5F78HR  Y |
| Chemical and physical data | |
| Formula | C6492H10000N1704O2038S44 |
| Molar mass | 148.4 kg/mol |
 NY (what is this?) (verify) | |
Enokizumab is a humanized monoclonal antibody designed for the treatment of asthma.[1]
Enokizumab was developed by MedImmune.
References
- ↑ "Statement On A Nonproprietary Name Adopted By The USAN Council: Enokizumab" (PDF). American Medical Association.
| IL-1 |
| ||||||
|---|---|---|---|---|---|---|---|
| IL-2 |
| ||||||
| IL-3 |
| ||||||
| IL-4 |
| ||||||
| IL-5 |
| ||||||
| IL-6 |
| ||||||
| IL-7 |
| ||||||
| IL-8 |
| ||||||
| IL-9 |
| ||||||
| IL-10 |
| ||||||
| IL-11 |
| ||||||
| IL-12 |
| ||||||
| IL-13 |
| ||||||
| IL-15 |
| ||||||
| IL-17 |
| ||||||
| IL-18 |
| ||||||
| IL-20 |
| ||||||
| IL-21 |
| ||||||
| IL-22 |
| ||||||
| IL-23 |
| ||||||
| IL-27 |
| ||||||
| IL-28 |
| ||||||
| IL-31 |
| ||||||
| IL1RL1 |
| ||||||
| IL1RL2 |
| ||||||
| Others |
| ||||||
| |||||||
This article is issued from Wikipedia - version of the 9/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.